Lorenzo Capone

Lorenzo Capone

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EMElisabetta Mormone
Elisabetta Mormone
ACAntonio Cisternino
Antonio Cisternino
LCLorenzo Capone
Lorenzo Capone
ECEugenio Caradonna
Eugenio Caradonna
ASAndrea Sbarbati
Andrea Sbarbati
Given the recent evidence in the clinical application of regenerative medicine, mostly on integumentary systems, we focused our interests on recent bladder regeneration approaches based on mesenchymal stem cells (MSCs), platelet-rich plasma (PRP), and hyaluronic acid (HA) in the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) in humans. IC/BPS is a heterogeneous chronic disease with not-well-understood etiology, characterized by suprapubic pain related to bladder filling and urothelium dysfunction, in which the impairment of immunological processes seems to play an important role. The histopathological features of IC include ulceration of the mucosa, edema, denuded urothelium, and increased detection of mast cells and other inflammatory cells. A deeper understanding of the molecular mechanism underlying this disease is essential for the selection of the right therapeutic approach. In fact, although various therapeutic strategies exist, no efficient therapy for IC/BPS has been discovered yet. This review gives an overview of the clinical and pathological features of IC/BPS, with a particular focus on the molecular pathways involved and a special interest in the ongoing few investigational therapies in IC/BPS, which use new regenerative medicine approaches, and their synergetic combination. Good knowledge of the molecular aspects related to stem cell-, PRP-, and biomaterial-based treatments, as well as the understanding of the molecular mechanism of this pathology, will allow for the selection of the right and best use of regenerative approaches of structures involving connective tissue and epithelia, as well as in other diseases.

Verified
Journal Article
Open access
PDF file
ACAntonio Cisternino
Antonio Cisternino
LCLorenzo Capone
Lorenzo Capone
ARAntonio Rosati
Antonio Rosati
CLCostanzo Latiano
Costanzo Latiano
NSNicola Sebastio
Nicola Sebastio
GCGiuseppe Cretì
Giuseppe Cretì
Introduction and objectives: The aim of the study was to evaluate genital sparing radical cystectomy surgery in female patients from the point of view of both oncologic and functional outcomes (with emphasis on urinary and sexual outcomes) in a single high-volume center for the treatment of muscular invasive bladder cancer. Materials and methods: Between January 2014 and January 2018, 14 female patients underwent radical cystectomy with preservation of genital organs (the entire vagina, uterus, fallopian tubes, ovaries) and orthotopic urinary neobladder (Padua neobladder). Inclusion criteria were recurrent T1G3 tumors; refractory tumors after BCG therapy without associated carcinoma in situ (CIS); T2 or T3a tumors entirely resected at endoscopic transurethral resection of the bladder and not involving urethra/bladder trigone. Exclusion criteria were: T3b or higher bladder cancer, associated CIS and involvement of urethra or bladder trigone. Oncological and histopathological outcomes (Overall Survival - OS, Recurrence Free Survival - RFS), urinary outcomes (day and night incontinence, intermittent catheterization use, Sandvik Score) and sexual outcomes (Female Sexual Function Index 19 FSFI-19) were considered. The average follow-up time was 56 months. Results: Considering oncological outcomes, histologic examination reported urothelial carcinoma in 13/14 patients; 8/13 patients (61.5%) had high grade T1 stage, 3/13 patients (23%) had high grade T2 stage and finally 2/13 patients (15.5%) had high-grade T3 stage. One patient presented with embryonal rhabdomyosarcoma completely excised after surgery (PT2aN0M0). No patient developed local or metastatic recurrence (RFS 100%); OS was 100%. Considering urinary continence outcomes, 12/14 patients retained daytime and nighttime continence (85.5%); 2/14 (14.5%) complained of low stress urinary incontinence daily and nighttime urinary leakage. The Sandvik Score showed complete continence in 7/14 patients (50%); mild degree incontinence in 6/14 patients without use of incontinence devices (43%); moderate degree of incontinence in one patient (7%). The FSFI administered at 1 year from the surgery showed sexual desire in all patients (100%); subjective arousal, achievement of orgasm and sexual satisfaction in 12/14 patients (85.5%); sufficient lubrication in 11/14 patients (78.5%). Only one patient (7%) complained about dyspareunia during sexual intercourse. Conclusions: Our study aims to demonstrate that genital-sparing radical cystectomy is a safe surgery in terms of oncologic outcomes and, most importantly, that it is beneficial in terms of urinary and sexual function. Indeed, patients’ quality of life together with their psychological and emotional health should be put on the same level as oncological safety. However, it is a treatment reserved for selected patients who are strongly motivated to preserve fertility and sexual function and thoroughly informed about the benefits and complications of such a procedure.

1 October 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
YSYazan Al Salhi
Yazan Al Salhi
AFAndrea Fuschi
Andrea Fuschi
GVGennaro Velotti
Gennaro Velotti
LCLorenzo Capone
Lorenzo Capone
SASara Aversa
Sara Aversa
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
Papillary renal cell carcinoma (PRCC) is a rare cancer and is the second most frequent histologic type among all renal cell carcinoma, accounting for up to 15%. A 72-year-old man underwent a right radical nephrectomy 7 years ago with final histopathology diagnosis of type 1 PRCC with negative surgical margins. Five years after surgery, computed tomography scan imaging showed the presence of multiple masses suspicious for node recurrences disease localized in the renal lodge, in the inter-aorto-caval space, at the iliac vessels bifurcation and right common iliac vessels. Patient underwent a robotic retroperitoneal lymphadenectomy. The histopathological examination confirmed the recurrence of type I papillary renal cancer in all the specimens. No further recurrences have been observed at 24-month follow-up after surgery. This report is the first describing a robot-assisted minimally invasive surgical excision for type I papillary renal cancer nodal and renal fossa recurrences.

26 September 2022 in Journal of Clinical and Medical Images, Case Reports
Verified
Journal Article
Closed access
LCLorenzo Capone
Lorenzo Capone
GCGiovanni Ciccarese
Giovanni Ciccarese
ACAntonio Cisternino
Antonio Cisternino
Pseudoaneurysm is a false aneurysm that occur at the site ofarterial injury that involves one or more layers of the arterialwall but no all three layers of the wall [1]. The renal artery pseudoaneurysm is a rare clinical entity due to iatrogenic procedures like percutaneous procedures, renal biopsy, nephrectomy or to penetrating or blunt traumas [2,3]. The clinical can be different according to patient blood pressure, blood flow and also to the effectiveness of the hemostasis. This complication can lead to hematuria, blood loss, and even hemorrhagic shock secondary to rupture (rare event but with a mortality rate as high as 80%) [4]. Aneurysms larger than 2 cm in diameter are considered to have a high risk of rupture, although ruptures have also been reported in smaller aneurysm [5].

31 May 2023
Verified
Book Chapter
Open access
PDF file
LCLorenzo Capone
Lorenzo Capone
The principal aim of this chapter is to evaluate the urodynamic and clinical outcomes at 6 months follow-up in men with or without significant IPP ( > 5 mm) undergoing HoLEP for BOO. Eight-four patients underwent HoLEP between January 2018 and December 2021. Inclusion criteria: men aged 50–75 years with prostate size from 30 to 100 grams, peak urinary flow rate less than 15 ml/s, and a diagnosis of BOO. At 6-month follow-up, urodynamics data show a statistically significant reduction in PdetOpen and PdetQmax compared with baseline in both IPP and no IPP groups. Statistically significant differences were found in maximal urodynamic bladder capacity before and after the operations in both groups as also IPSS data, Qmax, Qave, PVR and IPSS total score at 6 months when compared with preoperative data. HoLEP is efficient in improving functional outcomes and obstructive symptoms regardless of the presence of IPP. Surgeons can expect better postoperative outcomes in terms of Qmax, Qave and IPSS total score in patients with significant IPP.